References
- Qin YH, Zhou TB, Lei FY, et al. Cut-off values for serum matrix metalloproteinase-9: Is there a threshold to predict renal involvement for Henoch-Schonlein purpura in children? Nephrology (Carlton). 2011;16(1):93–99
- Zhou TB, Ou C, Qin YH, Luo W. A meta-analysis of the association between angiotensin-converting enzyme insertion/deletion gene polymorphism and Henoch-Schonlein purpura nephritis risk in Asian children. Clin Exp Rheumatol. 2012;30(2):315–316
- An J, Lu Q, Zhao H, Cao Y, Yan B, Ma Z. A study on the association between C1GALT1 polymorphisms and the risk of Henoch-Schonlein purpura in a Chinese population. Rheumatol Int. 2013;33(10):2539–2542
- Di B, Li X, Song L, Wang Q, Liu S. Association study of ACE and eNOS single nucleotide polymorphisms with Henoch-Schonlein purpura nephritis. Mol Med Rep. 2012;6(5):1171–1177
- Nalbantoglu S, Tabel Y, Mir S, Serdaroglu E, Berdeli A. Association between RAS gene polymorphisms (ACE I/D, AGT M235T) and Henoch-Schonlein purpura in a Turkish population. Dis Markers. 2013;34(1):23–32
- Wang JJ, Shi YP, Huang Y, Wu C, Li XC. Association of tumor necrosis factor-alpha gene polymorphisms with Henoch-Schonlein purpura nephritis in children. Zhongguo Dang Dai Er Ke Za Zhi. 2013;15(2):88–90
- Vecoli C. Endothelial nitric oxide synthase gene polymorphisms in cardiovascular disease. Vitam Horm. 2014;96:387–406
- Zhou TB, Xu HL, Yin SS. Association between endothelial nitric oxide synthase Glu298Asp gene polymorphism and diabetic nephropathy susceptibility. Ren Fail. 2013;35(1):173–178
- Zhou TB, Yin SS. Association of endothelial nitric oxide synthase Glu298Asp gene polymorphism with the risk of end-stage renal disease. Ren Fail. 2013;35(4):573–578
- Amoli MM, Garcia-Porrua C, Calvino MC, Ollier WE, Gonzalez-Gay MA. Lack of association between endothelial nitric oxide synthase polymorphisms and Henoch-Schonlein purpura. J Rheumatol. 2004;31(2):299–301
- An J, Yu J, Mei S, et al. Association of eNOS gene polymorphism with genetic susceptibility to Henoch-Schönlein purpura. J Mudanjiang Med Univ. 2012;33(1):1–3
- Cao N, Chen T, Guo ZP, Li MM, Jiao XY. Elevated serum levels of visfatin in patients with Henoch-Schonlein purpura. Ann Dermatol. 2014;26(3):303–307
- Ren P, Han F, Chen L, Xu Y, Wang Y, Chen J. The combination of mycophenolate mofetil with corticosteroids induces remission of Henoch-Schonlein purpura nephritis. Am J Nephrol. 2012;36(3):271–277
- Davin JC, Coppo R. Henoch-Schonlein purpura nephritis in children. Nat Rev Nephrol. 2014;10:563–573